These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 22245330)
1. Chemokine and chemokine receptor expression in kidney tumors: molecular profiling of histological subtypes and association with metastasis. Gahan JC; Gosalbez M; Yates T; Young EE; Escudero DO; Chi A; Garcia-Roig M; Satyanarayana R; Soloway MS; Bird VG; Lokeshwar VB J Urol; 2012 Mar; 187(3):827-33. PubMed ID: 22245330 [TBL] [Abstract][Full Text] [Related]
2. High expression of CXCR4, CXCR7 and SDF-1 predicts poor survival in renal cell carcinoma. Wang L; Chen W; Gao L; Yang Q; Liu B; Wu Z; Wang Y; Sun Y World J Surg Oncol; 2012 Oct; 10():212. PubMed ID: 23039915 [TBL] [Abstract][Full Text] [Related]
3. Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer. D'Alterio C; Consales C; Polimeno M; Franco R; Cindolo L; Portella L; Cioffi M; Calemma R; Marra L; Claudio L; Perdonà S; Pignata S; Facchini G; Cartenì G; Longo N; Pucci L; Ottaiano A; Costantini S; Castello G; Scala S Curr Cancer Drug Targets; 2010 Nov; 10(7):772-81. PubMed ID: 20578990 [TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic value of CXCL12/CXCR4/CXCR7 axis in clear cell renal cell carcinoma. Potić Floranović M; Ristić Petrović A; Veličković F; Janković Veličković L Clin Exp Nephrol; 2021 Oct; 25(10):1057-1069. PubMed ID: 34109508 [TBL] [Abstract][Full Text] [Related]
5. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells. Qiao N; Wang L; Wang T; Li H Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277 [TBL] [Abstract][Full Text] [Related]
6. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies. Khare T; Bissonnette M; Khare S Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991 [TBL] [Abstract][Full Text] [Related]
7. Expression of the glucocorticoid receptor in renal cell neoplasms: an immunohistochemical and quantitative reverse transcriptase polymerase chain reaction study. Yakirevich E; Matoso A; Sabo E; Wang LJ; Tavares R; Meitner P; Morris DJ; Pareek G; Delellis RA; Resnick MB Hum Pathol; 2011 Nov; 42(11):1684-92. PubMed ID: 21531004 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer. Wu W; Qian L; Chen X; Ding B Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521 [TBL] [Abstract][Full Text] [Related]
9. CXCR4 Expression is Associated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma. Goto M; Yoshida T; Yamamoto Y; Furukita Y; Inoue S; Fujiwara S; Kawakita N; Nishino T; Minato T; Yuasa Y; Yamai H; Takechi H; Seike J; Bando Y; Tangoku A Ann Surg Oncol; 2017 Mar; 24(3):832-840. PubMed ID: 26577115 [TBL] [Abstract][Full Text] [Related]
10. Expression of the CXCR4 and CXCR7 in renal cancers; can "the orphan receptor" predict the mortality? Floranović MP; Petrović AR; Veličković LJ Ann Diagn Pathol; 2021 Dec; 55():151829. PubMed ID: 34563828 [TBL] [Abstract][Full Text] [Related]
11. CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells. Ieranò C; Santagata S; Napolitano M; Guardia F; Grimaldi A; Antignani E; Botti G; Consales C; Riccio A; Nanayakkara M; Barone MV; Caraglia M; Scala S Cell Death Dis; 2014 Jul; 5(7):e1310. PubMed ID: 24991762 [TBL] [Abstract][Full Text] [Related]
12. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma. Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433 [TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of kidney cancer: association of hyaluronic acid family with histological subtypes and metastasis. Chi A; Shirodkar SP; Escudero DO; Ekwenna OO; Yates TJ; Ayyathurai R; Garcia-Roig M; Gahan JC; Manoharan M; Bird VG; Lokeshwar VB Cancer; 2012 May; 118(9):2394-402. PubMed ID: 21887686 [TBL] [Abstract][Full Text] [Related]
14. Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells. Luker KE; Lewin SA; Mihalko LA; Schmidt BT; Winkler JS; Coggins NL; Thomas DG; Luker GD Oncogene; 2012 Nov; 31(45):4750-8. PubMed ID: 22266857 [TBL] [Abstract][Full Text] [Related]
15. The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow. Shakir M; Tang D; Zeh HJ; Tang SW; Anderson CJ; Bahary N; Lotze MT Pancreas; 2015 May; 44(4):528-34. PubMed ID: 25872129 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes. Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095 [TBL] [Abstract][Full Text] [Related]
17. Involvement of CXCR4/CXCR7/CXCL12 Interactions in Inflammatory bowel disease. Werner L; Guzner-Gur H; Dotan I Theranostics; 2013; 3(1):40-6. PubMed ID: 23382785 [TBL] [Abstract][Full Text] [Related]
18. The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice. Petruzziello-Pellegrini TN; Yuen DA; Page AV; Patel S; Soltyk AM; Matouk CC; Wong DK; Turgeon PJ; Fish JE; Ho JJ; Steer BM; Khajoee V; Tigdi J; Lee WL; Motto DG; Advani A; Gilbert RE; Karumanchi SA; Robinson LA; Tarr PI; Liles WC; Brunton JL; Marsden PA J Clin Invest; 2012 Feb; 122(2):759-76. PubMed ID: 22232208 [TBL] [Abstract][Full Text] [Related]
19. Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma? Ng KL; Del Vecchio SJ; Samaratunga H; Morais C; Rajandram R; Vesey DA; Wood ST; Gobe GC Pathology; 2018 Aug; 50(5):504-510. PubMed ID: 29970253 [TBL] [Abstract][Full Text] [Related]
20. C-X-C chemokine receptor 7: a functionally associated molecular marker for bladder cancer. Yates TJ; Knapp J; Gosalbez M; Lokeshwar SD; Gomez CS; Benitez A; Ekwenna OO; Young EE; Manoharan M; Lokeshwar VB Cancer; 2013 Jan; 119(1):61-71. PubMed ID: 22736438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]